Q9CY64
Gene name |
Blvra |
Protein name |
Biliverdin reductase A |
Names |
BVR A, Biliverdin-IX alpha-reductase |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:109778 |
EC number |
1.3.1.24: With NAD(+) or NADP(+) as acceptor |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9CY64
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9CY64-F1 | Predicted | AlphaFoldDB |
27 variants for Q9CY64
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs13470683 | 2 | S>N | No | EVA | |
| rs222788723 | 41 | Y>F | No | EVA | |
| rs3388587484 | 43 | S>C | No | EVA | |
| rs3388576368 | 47 | L>F | No | EVA | |
| rs3388585203 | 56 | I>T | No | EVA | |
| rs253763408 | 63 | R>H | No | EVA | |
| rs3388589592 | 68 | D>E | No | EVA | |
| rs3388589969 | 76 | S>R | No | EVA | |
| rs3388591733 | 77 | S>P | No | EVA | |
| rs3388589519 | 79 | H>R | No | EVA | |
| rs243059682 | 81 | D>E | No | EVA | |
| rs3388589967 | 82 | Y>F | No | EVA | |
| rs3392171005 | 84 | R>G | No | EVA | |
| rs3388591814 | 107 | Q>R | No | EVA | |
| rs246415834 | 110 | W>C | No | EVA | |
| rs3388582060 | 110 | W>R | No | EVA | |
| rs3388581762 | 114 | A>T | No | EVA | |
| rs3392045000 | 130 | E>Q | No | EVA | |
| rs3392206939 | 137 | R>S | No | EVA | |
| rs33061043 | 192 | R>Q | No | EVA | |
| rs256600810 | 211 | P>T | No | EVA | |
| rs240345036 | 227 | H>Q | No | EVA | |
| rs259407944 | 275 | K>Q | No | EVA | |
| rs47356914 | 278 | L>M | No | EVA | |
| rs27416343 | 282 | E>G | No | EVA | |
| rs3388586311 | 283 | L>Q | No | EVA | |
| rs229518904 | 293 | R>Q | No | EVA |
No associated diseases with Q9CY64
1 regional properties for Q9CY64
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Homocysteine-binding domain | 8 - 309 | IPR003726 |
Functions
| Description | ||
|---|---|---|
| EC Number | 1.3.1.24 | With NAD(+) or NADP(+) as acceptor |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
5 GO annotations of molecular function
| Name | Definition |
|---|---|
| biliberdin reductase NAD+ activity | Catalysis of the reaction: bilirubin + NAD+ = biliverdin + NADH+ H+. |
| biliverdin reductase (NAD(P)+) activity | Catalysis of the reaction: bilirubin + NAD(P)+ = biliverdin + NAD(P)H + H+. |
| biliverdin reductase (NADP+) activity | Catalysis of the reaction: bilirubin + NADP+ = biliverdin + NADPH + H+. |
| nucleotide binding | Binding to a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose. |
| zinc ion binding | Binding to a zinc ion (Zn). |
1 GO annotations of biological process
| Name | Definition |
|---|---|
| heme catabolic process | The chemical reactions and pathways resulting in the breakdown of heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MSTEPKRKFG | VVVVGVGRAG | SVRIRDLKDP | HSSAFLNLIG | YVSRRELGSL | DNVRQISLED |
| 70 | 80 | 90 | 100 | 110 | 120 |
| ALRSQEVDVA | YICTESSSHE | DYIRQFLQAG | KHVLVEYPMA | LSFAAAQELW | ELAAQKGRVL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| HEEHIELLME | EFEFLKREVA | GKELLKGSLR | FTASPLEEEK | FGFPAFSGIS | RLTWLVSLFG |
| 190 | 200 | 210 | 220 | 230 | 240 |
| ELSLISATME | NRKEDQYMKM | TVQLETQNKS | PLSWIEEKGP | GLKRNRHISI | HFKSGSLEEV |
| 250 | 260 | 270 | 280 | 290 | |
| PNVGVNKNIF | LKDQDIFIQK | LLGQVSAEDL | AAEKKRILHC | LELASDIQRL | CHRKQ |